These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32470105)

  • 1. Use of nonopioid agents for inpatient pain management of sickle cell disease.
    Austin Szwak J
    Am J Health Syst Pharm; 2020 Jun; 77(13):1007-1008. PubMed ID: 32470105
    [No Abstract]   [Full Text] [Related]  

  • 2. The Opioid Drug Epidemic and Sickle Cell Disease: Guilt by Association.
    Ruta NS; Ballas SK
    Pain Med; 2016 Oct; 17(10):1793-1798. PubMed ID: 27152018
    [No Abstract]   [Full Text] [Related]  

  • 3. Sickle cell disease--pathophysiology and treatment.
    Redding-Lallinger R; Knoll C
    Curr Probl Pediatr Adolesc Health Care; 2006; 36(10):346-76. PubMed ID: 17055417
    [No Abstract]   [Full Text] [Related]  

  • 4. Dexmedetomidine relieves pain associated with acute sickle cell crisis.
    Phillips WJ; Gadiraju S; Dickey S; Galli R; Lerant AA
    J Pain Symptom Manage; 2007 Oct; 34(4):346-9. PubMed ID: 17903665
    [No Abstract]   [Full Text] [Related]  

  • 5. Dexmedetomidine as an Adjuvant to Analgesic Strategy During Vaso-Occlusive Episodes in Adolescents with Sickle-Cell Disease.
    Sheehy KA; Finkel JC; Darbari DS; Guerrera MF; Quezado ZM
    Pain Pract; 2015 Nov; 15(8):E90-7. PubMed ID: 26205912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of analgesics in the multicenter study of hydroxyurea in sickle cell anemia: effect of sex, age, and geographical location.
    Ballas SK; Bauserman RL; McCarthy WF; Castro OL; Smith WR; Waclawiw MA;
    Am J Hematol; 2010 Aug; 85(8):613-6. PubMed ID: 20568300
    [No Abstract]   [Full Text] [Related]  

  • 7. Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful Crises.
    Hagedorn JM; Monico EC
    Pediatr Emerg Care; 2019 Jan; 35(1):78-79. PubMed ID: 27902670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Chronic Pain and Opioid Usage in Adult Sickle Cell Disease Patients Referred to a Comprehensive Pain Clinic.
    Zoheiry N; Alkokani M; Ward R; Mailis A
    Pain Med; 2016 Nov; 17(11):2145-2146. PubMed ID: 27880652
    [No Abstract]   [Full Text] [Related]  

  • 9. Aligning New Approaches to Accelerate the Development of Non-opioid Analgesic Therapies.
    Sang CN; Schmidt WK
    Neurotherapeutics; 2020 Jul; 17(3):765-769. PubMed ID: 33058022
    [No Abstract]   [Full Text] [Related]  

  • 10. Pain Management in Patients With Hidradenitis Suppurativa Requiring Surgery.
    Puza CJ; Wolfe SA; Jaleel T
    Dermatol Surg; 2019 Oct; 45(10):1327-1330. PubMed ID: 30570515
    [No Abstract]   [Full Text] [Related]  

  • 11. Tramadol infusion for the pain management in sickle cell disease: a case report.
    Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
    Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrous oxide and morphine in children with sickle cell crisis.
    Carbajal R; Hubert P; Treluyer JM; Jouvet P; Olivier-Martin M
    Lancet; 1996 Jun; 347(9015):1621. PubMed ID: 8667885
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease.
    Han J; Saraf SL; Gowhari M; Hussain FA; Jain S; Kavoliunaite L; Molokie RE; Gordeuk VR
    Ann Pharmacother; 2022 Feb; 56(2):222-223. PubMed ID: 34151594
    [No Abstract]   [Full Text] [Related]  

  • 14. "I'm in Pain; Why Don't You Believe Me?" Pain Management in Sickle Cell Disease.
    Ellis G
    Am J Bioeth; 2021 Jan; 21(1):75-77. PubMed ID: 33373554
    [No Abstract]   [Full Text] [Related]  

  • 15. Sickle cell disease patients' perceptions of emergency department pain management.
    Porter J; Feinglass J; Artz N; Hafner J; Tanabe P
    J Natl Med Assoc; 2012; 104(9-10):449-54. PubMed ID: 23342819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature.
    Uprety D; Baber A; Foy M
    Ann Hematol; 2014 May; 93(5):769-71. PubMed ID: 24232306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.
    Kato-Lin YC; Krishnamurti L; Padman R; Seltman HJ
    Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massive hyperhomocysteinaemia as a complication of nitrous oxide inhalation.
    Faguer S; Ruiz J; Mari A
    Br J Clin Pharmacol; 2016 Feb; 81(2):391-2. PubMed ID: 26521848
    [No Abstract]   [Full Text] [Related]  

  • 19. The management of pain in sickle cell disease.
    Shapiro BS
    Pediatr Clin North Am; 1989 Aug; 36(4):1029-45. PubMed ID: 2666928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of a dedicated day hospital for management of acute sickle cell pain.
    Adewoye AH; Nolan V; McMahon L; Ma Q; Steinberg MH
    Haematologica; 2007 Jun; 92(6):854-5. PubMed ID: 17550862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.